# Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

> **NCT00041938** · PHASE3 · COMPLETED · sponsor: **Columbia University** · enrollment: 2305 (actual)

## Conditions studied

- Heart Disease
- Stroke
- Ischemic Heart Disease
- Myocardial Infarction

## Interventions

- **DRUG:** aspirin
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT00041938
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2011-08
- **Final completion:** 2014-07
- **Target enrollment:** 2305 (ACTUAL)
- **Last updated:** 2014-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041938, "Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00041938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*